Mount Sinai researchers, GenScript develop a COVID-19 antibody to treat sick patients
A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes the coronavirus disease.
